This is the authors' abstract. We don't add key points for this paper.
These data implicate ARID1A as a tumor-suppressor gene frequently disrupted in ovarian clear-cell and endometrioid carcinomas. Since ARID1A mutation and loss of BAF250a can be seen in the preneoplastic lesions, we speculate that this is an early event in the transformation of endometriosis into cancer. (Funded by the British Columbia Cancer Foundation and the Vancouver General Hospital–University of British Columbia Hospital Foundation.).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wiegand et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: